Genomic Cancer Panel and Profiling Market Set to Reach $26.59 Billion by 2033, Fueled by Advances in Precision Medicine

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application, Technology, End User, and Region - Analysis and Forecast, 2023-2033" report has been added to's offering.

The latest comprehensive analysis on the global genomic cancer panel and profiling market projects an accelerated growth trajectory, expecting to surge from $9.90 billion in 2022 to a staggering $26.59 billion by 2033. This robust expansion, with a compound annual growth rate (CAGR) of 9.43% during the 2023-2033 forecast period, is primarily driven by groundbreaking advancements in genomic research coupled with a heightened focus on precision medicine within oncology.

The surging demand for early cancer detection methods and tailored treatment plans stem from an ever-evolving landscape in healthcare, where personalization and precision stand at the forefront. The rise in the execution of liquid biopsy tests and the heightened risk of cancer due to lifestyle changes contribute significantly to the thrust propelling the market forward.

Key Market Segments Witnessing Notable Growth

  • Solid and Liquid Tissue Testing: Liquid tissue testing gains prominence, signaling a shift towards non-invasive testing methods critical for early diagnosis and management.
  • Cancer Panel Types: The dominance of multi-gene panel testing underscores the value of multifaceted gene analysis in driving oncological insights.

Impact Transforming Cancer Treatment Practices

Genomic cancer panels and profiling are instrumental in the revolution of treatment personalization, enabling clinicians to devise patient-specific strategies based on genetic makeup. In addition, these panels facilitate early cancer detection, provide valuable prognostic information, and bolster clinical trial designs. Notably, advancements have also led to more cost-effective genomic sequencing, allowing for wider access to personalized treatments.

Regional Insights and Competitive Landscape

Within the regional segment analysis, North America stands out as the market leader, credited to its robust healthcare infrastructure and early adoption of advanced technologies. However, the Asia-Pacific region demonstrates the highest CAGR due to rapidly growing economies embracing genomic cancer panel technologies.

Pivotal developments in the field include regulatory approvals and strategic partnerships aimed at expanding reach and enhancing precision in cancer treatment. Innovations in genomic profiling, liquid biopsy, and collaborative efforts amplify the capability to offer bespoke therapeutics across diverse patient populations.

Demand Dynamics in the Genomic Cancer Panel and Profiling Market

Market growth is driven by the necessity for precision profiling in cancer diagnosis, with developed countries showing significant demand due to their aging populations. While reimbursement challenges pose constraints, the burgeoning pipeline of genomic cancer profiling tests presents vast opportunities for early detection and treatment customization, positioning the market for substantial growth in the coming years.

This market's extensive segmentation analysis provides a panoramic view of lucrative pockets and segments with pronounced growth potential. These insights will prove invaluable for organizations strategizing product innovation paths and looking to capitalize on emerging trends in precision medicine.

Drivers of Market Expansion:
Key factors propelling market expansion include the growing imperative for personalized medicine, technological advancements in genomic sequencing, and increased investment in cancer research.

How This Report Adds Value

The report's exhaustive segment-wise analysis, ranging from tissue testing to end users, affords organizations a vivid blueprint to navigate the competitive landscape. The findings also elaborate on the pivotal role of next-generation sequencing and other technologies in shaping the future of oncology.

Emphasizing product and innovation strategies, the report encapsulates integral considerations and assumptions in market validation. This meticulous approach underpins the report's reliability, offering an ally to businesses in charting their trajectory in the genomic cancer panel and profiling market.

Boasting a harmonious blend of primary insights and comprehensive secondary research, the report synthesizes expert opinions with evidence-based projections. The detailed methodology entrenches its relevance, furnishing organizations with a pivotal resource for informed decision-making.

The analysis incorporates the diligent profiling of key market players, providing a competitive synopsis indispensable for understanding the market's current state and anticipating future shifts. It charts the trajectories of established names as well as disruptive newcomers mapping the future of cancer care.

The report stands as an authoritative document for entities across the healthcare spectrum, offering a foundation for strategic decision-making that taps into the myriad opportunities within the growing genomic cancer panel and profiling market.

Key Attributes

Report AttributeDetails
No. of Pages198
Forecast Period2023 - 2033
Estimated Market Value (USD) in 2023$10.8 Billion
Forecasted Market Value (USD) by 2033$26.59 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal

Companies Mentioned

  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Burning Rock DX
  • Caris Life Sciences
  • Danaher Corporation (Integrated DNA Technologies, Inc.)
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Fulgent Genetics
  • Genecast Biotechnology Co., Ltd
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings.
  • Paragon Genomics
  • Tempus
  • Thermo Fisher Scientific Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Genomic Cancer Panel and Profiling Market

Contact Data